Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-012362

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
May 4, 2017
Accepted (ET)
May 8, 2017 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001F1,F2May 4, 2017A1,278,471—A1,278,471ISee Footnote
Common Stock, par value $0.0001F1,F3May 4, 2017A36,785—A36,785ISee Footnote
Common Stock, par value $0.0001F1,F4May 4, 2017A4,455—A4,455ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses